We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN icon
51
Lennar Class A
LEN
$20.4B
$808K 0.3%
6,658
-475
-7% -$51.8K
APRN
52
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$801K 0.3%
137,123
+44,648
+48% +$302K
CMI icon
53
Cummins
CMI
$88.7B
$783K 0.29%
3,194
-21
-0.7% -$4.75K
VYX icon
54
NCR Voyix
VYX
$1.16B
$777K 0.29%
50,259
+34,911
+227% +$504K
ACN icon
55
Accenture
ACN
$105B
$764K 0.28%
2,475
– –
CANO
56
DELISTED
Cano Health, Inc.
CANO
$683K 0.25%
4,911
-1,504
-23% -$193K
CYRX icon
57
CryoPort
CYRX
$741M
$676K 0.25%
39,160
+3,750
+11% +$76.7K
ADM icon
58
Archer Daniels Midland
ADM
$37.4B
$655K 0.24%
8,670
-99
-1% -$7.5K
PRFT
59
DELISTED
Perficient Inc
PRFT
$646K 0.24%
7,747
+2,653
+52% +$195K
PKG icon
60
Packaging Corp of America
PKG
$22.5B
$642K 0.24%
4,861
-1,158
-19% -$155K
HBI
61
DELISTED
Hanesbrands
HBI
$619K 0.23%
+136,352
New +$623K
QUOT
62
DELISTED
Quotient Technology Inc
QUOT
$592K 0.22%
154,116
+590
+0.4% +$1.83K
JNPR
63
DELISTED
Juniper Networks
JNPR
$574K 0.21%
18,320
-107
-0.6% -$3.3K
PII icon
64
Polaris
PII
$3.99B
$555K 0.2%
4,586
-27
-0.6% -$2.98K
CB icon
65
Chubb
CB
$137B
$547K 0.2%
2,842
-29
-1% -$5.68K
ADTN icon
66
Adtran
ADTN
$611M
$526K 0.19%
49,955
+25,869
+107% +$257K
IYW icon
67
iShares US Technology ETF
IYW
$24.8B
$524K 0.19%
4,812
– –
PERI icon
68
Perion Network
PERI
$380M
$523K 0.19%
17,046
+93
+0.5% +$3.19K
PFE icon
69
Pfizer
PFE
$149B
$518K 0.19%
14,120
-136,610
-91% -$5.32M
GD icon
70
General Dynamics
GD
$105B
$513K 0.19%
2,385
-30
-1% -$6.47K
TGTX icon
71
TG Therapeutics
TGTX
$7.58B
$508K 0.19%
+20,442
New +$528K
GIS icon
72
General Mills
GIS
$19.3B
$507K 0.19%
6,605
-47
-0.7% -$4.02K
QCOM icon
73
Qualcomm
QCOM
$168B
$497K 0.18%
4,177
-30
-0.7% -$3.45K
TLYS icon
74
Tilly's
TLYS
$126M
$496K 0.18%
+70,778
New +$519K
BLK icon
75
Blackrock
BLK
$175B
$495K 0.18%
716
-386
-35% -$259K
1 2
3
4 5

Similar funds

RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.